Fibromyalgia has a larger impact on physical health than on psychological health, yet both are markedly affected: The al-Ándalus project
Introduction
Fibromyalgia is a chronic musculoskeletal pain condition of unknown etiology. General prevalence of fibromyalgia varies from 0.5% to 5% depending on the different countries [1], [2], [3]. Similarly to the differences observed in the fibromyalgia prevalence among countries [1], [2], [3], the specific characteristics and symptoms reported by patients with fibromyalgia might differ depending on the region. In fact, previous studies have shown geographical variations in reported symptoms among patients with chronic widespread musculoskeletal pain [4], [5]. Fibromyalgia patients are a heterogeneous group, and the rating, number, and impact of different symptoms are expected to vary between different populations.
Fibromyalgia has become a worryingly health condition in our modern society, and its treatment implies time-consuming and high economic burdens [1]. Beyond a chronic widespread pain condition, fibromyalgia has recently been defined as a complex dimensional disorder with pain as its main symptom [2], and the inclusion of equally presumable important non-pain symptoms, such as fatigue, stiffness, cognitive problems, depression, anxiety, and a long list of other complaints [2], [6], [7]. This new approach highlights the need to know which of this large variety of symptoms are more characteristic of this disease, which might help in its accurate management.
According to Queiroz [3], epidemiological studies are important to better understand the extent of the problem in specific settings. No previous large population-based studies examining a vast variety of symptoms have been carried out previously in Spanish fibromyalgia patients and an age-matched control group. Furthermore, it is unknown if fibromyalgia affects more severely those components related to physical (e.g., functionality), or psychological domains (e.g., depression). A deep study of the fibromyalgia׳s key symptoms may provide a more fitted and appropriate guidance for treatment decisions and strategies. Therefore, the present study aimed (1) to characterize a representative sample of fibromyalgia patients from Southern Spain (Andalusia) in a set of relevant factors known to be related to this disease. This will provide useful reference values for clinicians and researchers so that they can better interpret their evaluations according to our population-based sample. (2) Many symptoms have been suggested to be related to fibromyalgia, but it is unknown which of them are more specific of the disease. In the present study, we will include a region and age-matched non-fibromyalgia sample in other to distinguish specific factors of the disease from other symptoms that might also exist in non-fibromyalgia women. For this purpose, we will use standardized statistic (effect size) to be able to compare different factors and dimensions. (3) A “global physical component” and a “global psychological component” will be created to clarify which of them is more affected in fibromyalgia patients compared with controls.
Section snippets
Participants
In order to obtain a fibromyalgia sample representative of the Andalusian population, the sample size needed was calculated (n = 300). Then, a sex and province proportional recruitment was planned (Supplementary Table 1). Fibromyalgia patients were recruited from different fibromyalgia associations via e-mail, letter, or telephone. We also asked those fibromyalgia patients interested in participate to recruit a pairwise non-fibromyalgia individual (control) with similar age and
Results
The socio-demographic variables of the study groups are shown in Table 1. BMI differed between fibromyalgia and control women (28.6 vs. 26.7 kg/m2, respectively; P < 0.001). There were differences in educational status between women groups (P = 0.018), with a greater percentage of primary school in fibromyalgia compared to controls (47.8% and 39.0%, respectively) and lower percentage of university higher degree in fibromyalgia compared to controls (5.0% and 9.9%, respectively). Current
Discussion
As expected, the current study showed large differences in general tenderness, impact of fibromyalgia, fatigue, health-related quality of life, depression, and anxiety in fibromyalgia women compared to control women. In addition, the only difference found on cognitive performance was observed in delayed recall, and the effect size was low. Overall, the differences presented very large effect sizes. Pain was confirmed as the most important and characteristic symptom distinguishing fibromyalgia
Conclusions
The results of the present study suggest that fibromyalgia must be understood as a complex dimensional disorder beyond chronic widespread pain condition. Despite pain remains as the primary symptom, the overall impact of fibromyalgia, general fatigue, health-related quality of life, depression, and anxiety are also characteristics to this population. Furthermore, the cognitive performance seems not to be as impaired as it had been suggested. Treatment options should focus on both physical and
Acknowledgements
We thank all the members from the CTS-545 research group involved in the field work. We also gratefully acknowledge all the study participants for their collaboration.
References (47)
- et al.
Prevalence of fibromyalgia: a survey in five European countries
Semin Arthritis Rheum
(2010) - et al.
Epidemiology of chronic musculoskeletal pain
Best Pract Res Clin Rheumatol
(2007) - et al.
Survey of chronic pain in Europe: prevalence, impact on daily life, and treatment
Eur J Pain
(2006) - et al.
“Mini-mental state”. A practical method for grading the cognitive state of patients for the clinician
J Psychiatr Res
(1975) - et al.
Pressure pain thresholds of tender point sites in patients with fibromyalgia and in healthy controls
Eur J Pain
(2004) - et al.
Self-assessed physical function levels of women with fibromyalgia: a national survey
Womens Health Issues
(2008) - et al.
Disruption of cognitive function in fibromyalgia syndrome
Pain
(2008) - et al.
Fibromyalgia prevalence, somatic symptom reporting, and the dimensionality of polysymptomatic distress: results from a survey of the general population
Arthritis Care Res (Hoboken)
(2013) Worldwide epidemiology of fibromyalgia
Curr Pain Headache Rep
(2013)- et al.
Identifying fibromyalgia-associated symptoms and conditions from a clinical perspective: a step toward evaluating healthcare resource utilization in fibromyalgia
Pain Pract
(2010)
Validation of the modified 2010 American College of Rheumatology diagnostic criteria for fibromyalgia in a Spanish population
Rheumatology (Oxford)
The American College of Rheumatology 1990 criteria for the classification of fibromyalgia. Report of the Multicenter Criteria Committee
Arthritis Rheum
The Revised Fibromyalgia Impact Questionnaire (FIQR): validation and psychometric properties
Arthritis Res Ther
Distinguishing fibromyalgia from rheumatoid arthritis and systemic lupus in clinical questionnaires: an analysis of the revised Fibromyalgia Impact Questionnaire (FIQR) and its variant, the Symptom Impact Questionnaire (SIQR), along with pain locations
Arthritis Res Ther
Fatigue in the general population
Onkologie
Multidimensional fatigue inventory: Spanish adaptation and psychometric properties for fibromyalgia patients. The Al-Andalus study
Clin Exp Rheumatol
The Spanish version of the SF-36 health survey (the SF-36 health questionnaire): an instrument for measuring clinical results
Med Clin (Barc)
Cognitive impairment in patients with fibromyalgia syndrome as assessed by the mini-mental state examination
BMC Musculoskelet Disord
An inventory for measuring depression
Arch Gen Psychiatry
Paced auditory serial-addition task: a measure of recovery from concussion
Percept Mot Skills
Performance of normal adults on Rey Auditory Learning Test: a pilot study
Arq Neuropsiquiatr
Effect size, confidence interval and statistical significance: a practical guide for biologists
Biol Rev Camb Philos Soc
Cited by (0)
This study was supported by the Spanish Ministry of Science and Innovation (I+D+I DEP2010-15639, grants: BES-2011-047133, RYC-2011-09011); the Consejeria de Turismo, Comercio y Deporte (CTCD-201000019242-TRA); the Spanish Ministry of Education (AP-2010-0963); Granada Research of Excelence Initiative on Biohealth (GREIB), Campus BioTic, University of Granada, Spain; and the European University of Madrid, Escuela de Estudios Universitarios Real Madrid (2010/04RM).